Sarah Canon Research Institute

Nashville, Tennessee 37203

1 studies enrolling now · 2 studies all time

What they study most

Acute Lymphoblastic Leukemia, Hematologic Malignancy, Malignant Lymphoma, Mantle Cell Lymphoma

Studies at this site

• Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Brexucabtagene Autoleucel — Available (expanded access)
• Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer — Completed